To provide a novel combination of antitumor agents that can significantly shrink tumors by synergistic antitumor action without increasing side effects.SOLUTION: Provided is an antitumor composition comprising the following compound (B) or a salt thereof for use in combination with the following at least one antitumor agent (A) selected from the group consisting of alkylating agents, CD20 recognition molecules,
DNA methylation inhibitors,
pyrimidine antimetabolites,
purine antimetabolites, antifolates, Bcl-2 inhibitors, and
tyrosine kinase inhibitors, the compound (B) or a salt thereof being represented by the following formula (1) where: R1 represents a
halogen atom, an
aryl group, an aryloxy group, or a lower
alkyl group optionally substituted with one or more
halogen atoms; R2 represents a
hydrogen atom, a
halogen atom, a lower
alkyl group, or a lower
alkoxy group; and m represents an integer of 1 to 3, provided that when m represents 2 or 3, R1 may be the same or different.SELECTED DRAWING: None